Why the study?
Although associations between obesity and comorbidities favor worse COVID-19 outcomes, how these factors interrelate and whether effects differ between men and women remained unclear.
Does the impact of body mass index (BMI) and comorbidities on mortality differ by sex in hospitalized COVID-19 patients?
Does the impact of body mass index (BMI) and comorbidities on mortality differ by sex in hospitalized COVID-19 patients?
The impact of obesity on COVID-19 mortality differs by sex, with a direct association in men and an indirect, comorbidity-mediated association in women, highlighting the need for sex-specific approaches to manage obesity.
Associations between obesity, comorbidities, and COVID-19 outcomes by sex and BMI remain hypothesis-generating; prospective studies needed to clarify effects.
Previous studies have shown that associations between obesity and other comorbidities favor worse outcomes in COVID-19. However, it is not clear how these factors interrelate and whether effects on men and women differ. We conducted an observational, cross-sectional study using a national COVID-19 inpatient database. We studied differences in direct and indirect effects of obesity and comorbidities according to sex and body mass index (BMI) categories in hospitalized COVID-19 patients in Brazil using path analysis models and logistic regression. For men, path analysis showed a direct association between BMI and death and a negative correlation of death and chronic cardiovascular disease (CCD). For women, the association of BMI and death was indirect, mediated by admission to the ICU and comorbidities and association with CCD was non-significant. In the logistic regression analyses, there was a positive association between death and BMI, age, diabetes mellitus, kidney and lung diseases and ICU admission. We highlight the need to consider the distinct impact of obesity and sex on COVID-19, of monitoring of BMI and of the design for specific male-targeted approaches to manage obesity.
No takes yet. Share an insight, caveat, or question.
Reis et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: